Related Experiment Video
Updated: Mar 29, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
Development and Validation of an Interface Between the BIANCA Biophysical Model and Geant4 for Particle Therapy
Mario P Carante1,2, Aurora Madonnini1, Alice Casali1,2
1Physics Department, University of Pavia, Via Bassi 6, I-27100 Pavia, Italy.
None:
Objectives: The main aim of this study consists of testing the consistency and reliability of the BIANCA (BIophysical ANalysis of Cell death and chromosome Aberrations) biophysical model across different radiation transport codes in the framework of cancer ion-therapy research. Methods: Spread-Out Bragg Peak (SOBP) profiles for protons, helium ions and carbon ions were simulated at three different depth ranges (2-3 cm, 5-8 cm, and 10-15 cm) applying two radiation transport codes, FLUKA and Geant4. While BIANCA has been interfaced to FLUKA in a previous work, an interface with Geant4 was purposely developed in this work. Cell survival along all considered SOBP profiles was predicted by BIANCA for two cell lines with very different radiosensitivities: Squamous Cell Carcinoma (SCC), with α/β = 12.68 Gy, and chordoma, with α/β = 2.37 Gy. The agreement between the predictions obtained from the two approaches was quantitatively evaluated by means of Root Mean Square Error (RMSE) and Gamma Index analysis, both for physical dose distributions and for cell survival predictions. Results: The comparison between FLUKA and Geant4 simulations demonstrated good agreement. The Gamma Index analysis yielded passing rates exceeding 94.9% for physical dose profiles (criteria: 3%/2 mm) and 96.0% for cell survival probabilities (criteria: 2%/2 mm) across all considered ion species (protons, He, C) and depths. Root Mean Square Error (RMSE) analysis confirmed average discrepancies below 2.5% for physical dose and 1% for biological survival. Conclusions: This study shows that the BIANCA model can be applied to predict cell killing along hadron therapy beams when interfaced both with FLUKA and with Geant4. Furthermore, the successful implementation of the interface with Geant4 expands the accessibility and applicability of BIANCA, paving the way for its future integration into different transport codes and/or treatment planning systems.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022